Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 50 of 112

TitleReference numberPublishedLast updated
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive careHTG607
Glaucoma: diagnosis and managementNG81
Sodium zirconium cyclosilicate for treating hyperkalaemiaTA599
Rehabilitation after traumatic injuryNG211
Smart Peak Flow for monitoring asthmaMIB282
Cabotegravir with rilpivirine for treating HIV-1TA757
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsyTA758
Prostate cancerQS91
Endo-SPONGE for treating low rectal anastomotic leakHTG605
Prostate cancer: diagnosis and managementNG131
Colorectal cancerNG151
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754
Transanal total mesorectal excision for rectal cancerHTG603
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseHTG604
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infectionsHTG602
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Urinary incontinence in womenQS77
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Dupilumab for treating severe asthma with type 2 inflammationTA751
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
Brain tumours (primary) and brain metastases in over 16sQS203
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemiaMIB278
CerebAir for continuous EEG monitoring in intensive careMIB279
Paige Prostate for prostate cancerMIB280
Synergo for non-muscle-invasive bladder cancerHTG601
Fever in under 5s: assessment and initial managementNG143
Givosiran for treating acute hepatic porphyriaHST16
Chronic kidney disease: assessment and managementNG203
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failureHTG599
Coronary sinus narrowing device implantation for refractory anginaHTG600
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoeaHTG598
Acute heart failure: diagnosis and managementCG187
Heart valve disease presenting in adults: investigation and managementNG208
Nintedanib for treating progressive fibrosing interstitial lung diseasesTA747
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancerTA746
Upadacitinib for treating moderate rheumatoid arthritisTA744
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)TA745
Inducing labourNG207
Inducing labourQS60
24/7 EEG SubQ for epilepsyMIB277
Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and managementNG206
Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancerTA740
Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancerTA741
Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitableTA739
Genicular artery embolisation for pain from knee osteoarthritisHTG595
Laparoscopic renal denervation for loin pain haematuria syndromeHTG596
Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis accessHTG597

Results per page

  1. 10
  2. 25
  3. 50
  4. All